Physiological Variability Index for WLST Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to accurately predict the time to death after withdrawal of life-sustaining therapy (WLST) in intensive care unit patients, leading to distress for families and inefficiencies in organ donation due to organ ischemia concerns.
Innovation Solution
A system and method utilizing variability measurements from physiological waveforms to estimate the probability of death or inadequate organ perfusion, integrated with clinical variables to provide automated decision support for clinicians.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If clinical variables such as physician opinion, pH, Glasgow Coma Scale, and blood pressure are used to predict time to death after WLST, then prediction capability is attempted, but accuracy is insufficient and external validation performance is poor
Solution Approach 1:
The patent transforms traditional clinical variables into variability measurements by analyzing changes in physiological parameters over time. Instead of using static values like blood pressure or Glasgow Coma Scale, the system measures the variability (standard deviation, coefficient of variation) of these parameters across multiple time points, capturing dynamic physiological deterioration patterns that predict time to death with higher accuracy and better external validation performance
Solution Approach 2:
The patent shifts from static clinical assessments to dynamic monitoring by continuously measuring physiological parameters and analyzing their temporal variability. The system tracks how variability changes over time windows (e.g., 30-minute intervals) to predict imminent death, capturing the evolving physiological state rather than relying on single-point measurements
2Loss of time
If organ donation teams wait for functional warm ischemia onset (systolic blood pressure <50 mmHg) to begin retrieval, then protocol requirements are met, but 40% of potential donors fail to die within acceptable ischemia limits (1-2 hours)
Solution Approach 1:
The patent enables preliminary identification of patients who will die within the acceptable ischemia time window (1-2 hours) by analyzing variability patterns before WLST and in the early post-WLST period. This allows donation teams to prioritize these identified patients for immediate retrieval preparation, ensuring they receive organs within the viable time window while avoiding unnecessary waiting for patients who will not die in time
Solution Approach 2:
The system provides continuous feedback on predicted time to death based on real-time variability monitoring, allowing donation teams to adjust their retrieval timing and resource allocation dynamically. The feedback loop enables optimization of retrieval schedules to match actual patient trajectories, improving the match between predicted time of death and actual retrieval timing
3Measurement precision
If variability measurements from physiological waveforms are used to estimate probability of death, then prediction accuracy is enhanced, but system complexity increases requiring integration with existing clinical variables
Solution Approach 1:
The patent designs the variability measurement system to work with existing physiological waveform data already captured by standard ICU monitoring equipment. By leveraging universally available data streams (ECG, blood pressure, respiratory waveforms) and computing variability metrics from these existing signals, the system avoids requiring new specialized sensors or devices, thereby reducing implementation complexity while maintaining high prediction accuracy
Solution Approach 2:
The patent combines variability measurements with traditional clinical variables in an integrated prediction framework. Rather than replacing existing clinical assessment tools, the system merges variability-based predictions with conventional variables (pH, Glasgow Coma Scale, blood pressure) to create a composite prediction model that leverages the strengths of both approaches while maintaining compatibility with existing clinical workflows
Data Source
AI summary
A system and method are provided that employ the variability of physiological waveforms to estimate the time to death after WLST, or time to inadequate organ perfusion. From the variability data one can derive an index subsequently used to determine the probability of death (or inadequate organ perfusion) within a given time frame in an automated fashion from bedside monitors in the intensive or post-anesthesia care unit. The resulting variability index can also be combined with the clinical variables used in other death prediction tools to enhance the performance and outcome when compared to existing models. In at least one implementation, variability monitoring at the bedside could be used to provide estimates of the probability that a patient will die within a certain time frame after WLST. These estimates could be used to reduce the distress of the patients' families, as well as optimize the use of resources surrounding donation.